GE Healthcare
BGS US launches state-of-the-art E-Beam sterilization facility
The technology BGS US is using in its new U.S. facility is increasingly being used as an alternative to gamma irradiation and has proven to be highly efficient for sterilization of medical devices.
More in GE Healthcare
2025 medtech M&A trend: Carve-outs and divestitures
These transactions – where companies spin off, sell, or reallocate parts of their business – reshape portfolios, redefine priorities, and unlock value across the healthcare ecosystem.
Medtech innovator selects 65 startups for 2025 accelerator cohort
Top 4% of global applicants selected to compete for $800K in non-dilutive funding and unmatched industry access; Up to 13 companies to participate in American Heart Association and American Society of Plastic Surgeons Specialty Accelerator Tracks.
Top 10 medical device companies by revenue 2020 vs 2021
Medtronic, Abbot, Johnson & Johnson, Siemens Healthineers, BD, Philips, GE Healthcare, Baxter, Cardinal Health, Stryker
Top 10 Global Medical Device Companies
Medical device manufacturing’s worldwide revenue exceeds $407 billion and projections are for continued, strong growth fueled by an aging population and response to COVID-19.
Global ventilator market
A necessary medical device prior to the COVID-19 global pandemic, demand for all types of ventilators has grown exponentially with the forecast following suit.
Moving from ventilators to testing
Ventilators are being produced; Now it’s a push for testing, but the answers vary on how much is necessary.
From Three Units to Thousands Webinar
Hear how MedWorld Advisors helped facilitate Ford, GE Healthcare, and Airon's partnership during a global pandemic - COVID-19 - filling a critical need for ventilators.
Manufacturing: Producing, designing, delivering, helping during COVID-19
Manufacturers around the globe are offering their services to help in the battle against COVID-19.
Global medical device industry to 2024
Medtech industry is projected to grow at a compound annual growth rate (CAGR) of 5.6% to $595 billion by 2024.
GE Healthcare, Vanderbilt University Medical Center partner
Artificial intelligence (AI)-powered applications will help predict how individual patients will respond to immunotherapies in advance of treatment.
